Diabetes Care 27:880-884, 2004
© 2004 by the American Diabetes Association, Inc.
Epidemiology/Health Services/Psychosocial Research Original Article |
Preclinical Atherosclerosis and Inflammation in 61-Year-Old Men With Newly Diagnosed Diabetes and Established Diabetes
Vilborg Sigurdardottir, MD,
Björn Fagerberg, MD, PHD and
Johannes Hulthe, MD, PHD
From the Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, Gothenburg, Sweden
Address correspondence and reprint requests to Vilborg Sigurdardottir, Wallenberg Laboratory, Physiology Group, Sahlgrenska University Hospital, S-413 45 Gothenburg, Sweden. E-mail: vilborg{at}wlab.wall.gu.se
OBJECTIVEThe aim of this study was to investigate the occurrence of subclinical atherosclerosis and underlying mechanisms in men with newly diagnosed diabetes and established diabetes compared with healthy control subjects.
RESEARCH DESIGN AND METHODSIn a population-based study of 61-year-old Caucasian men (n = 271) with established diabetes (n = 50) and newly diagnosed diabetes (n = 24) and healthy control subjects (n = 197), standard risk factors and highly sensitive (hs) C-reactive protein (CRP) were measured. Ultrasound measurements of intima-media thickness (IMT) were performed bilaterally in the common carotid artery, and a composite measure was calculated from common carotid and carotid bulb IMT (composite IMT). The plaque status was assessed.
RESULTSComposite IMT and carotid plaque size increased gradually among the healthy control subjects, newly diagnosed diabetic patients, and established diabetic patients (P for trend 0.001, respectively). CRP was higher in newly and established diabetes (NS between diabetes groups) compared with healthy control subjects (P < 0.001). Total cholesterol levels were lower in newly diagnosed diabetes (5.51 ± 1.13 mmol/l, P < 0.05) and established diabetes (5.45 ± 1.15 mmol/l, P < 0.01) compared with those of healthy control subjects (5.77 ± 1.03 mmol/l). In men with diabetes (n = 74), diabetes onset status (newly diagnosed versus established), waist-to-hip ratio (WHR), and serum triglycerides, but not CRP, explained 16% of the variance in composite IMT.
CONCLUSIONSThis is the first study to show increased preclinical atherosclerotic changes (IMT and plaque size) and increased inflammation (hs-CRP) in men with newly diagnosed diabetes as well as in patients with established diabetes compared with healthy control subjects. WHR, diabetes onset status (newly diagnosed versus established), and triglycerides, but not CRP, were independent correlates of carotid artery IMT in men with diabetes.
Abbreviations: CCA, common carotid artery CRP, C-reative protein FPG, fasting plasma glucose hs, highly sensitive IMT, intima-media thickness OGTT, oral glucose tolerance test WHR, waist-to-hip ratio

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Mita, H. Watada, T. Shimizu, Y. Tamura, F. Sato, T. Watanabe, J. B. Choi, T. Hirose, Y. Tanaka, and R. Kawamori
Nateglinide Reduces Carotid Intima-Media Thickening in Type 2 Diabetic Patients Under Good Glycemic Control
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2007;
27(11):
2456 - 2462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Ostling, B. Hedblad, G. Berglund, and I. Goncalves
Increased Echolucency of Carotid Plaques in Patients With Type 2 Diabetes
Stroke,
July 1, 2007;
38(7):
2074 - 2078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P F Dullaart, R. de Vries, A. van Tol, and W. J Sluiter
Lower plasma adiponectin is a marker of increased intima-media thickness associated with type 2 diabetes mellitus and with male gender
Eur. J. Endocrinol.,
March 1, 2007;
156(3):
387 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Guan, C. Hudson, T. Wong, M. Kisilevsky, R. K. Nrusimhadevara, W. C. Lam, M. Mandelcorn, R. G. Devenyi, and J. G. Flanagan
Retinal Hemodynamics in Early Diabetic Macular Edema
Diabetes,
March 1, 2006;
55(3):
813 - 818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Davidsson, J. Hulthe, B. Fagerberg, B.-M. Olsson, C. Hallberg, B. Dahllof, and G. Camejo
A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes
J. Lipid Res.,
September 1, 2005;
46(9):
1999 - 2006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Veiraiah
Hyperglycemia, Lipoprotein Glycation, and Vascular Disease
Angiology,
July 1, 2005;
56(4):
431 - 438.
[Abstract]
[PDF]
|
 |
|
Copyright © 2004 by the American Diabetes Association.
|
|
| |
|